Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns

Globally, pneumonia is a serious public health concern and a major cause of mortality and morbidity. Despite advances in antimicrobial therapies, microbiological diagnostic tests and prevention measures, pneumonia remains the main cause of death from infectious disease in the world. An important reason for the increased global mortality is the impact of pneumonia on chronic diseases, along with the increasing age of the population and the virulence factors of the causative microorganism. The increasing number of multidrug-resistant bacteria, difficult-to-treat microorganisms, and the emergence of new pathogens are a major problem for clinicians when deciding antimicrobial therapy. A key factor for managing and effectively guiding appropriate antimicrobial therapy is an understanding of the role of the different causative microorganisms in the etiology of pneumonia, since it has been shown that the adequacy of initial antimicrobial therapy is a key factor for prognosis in pneumonia. Furthermore, broad-spectrum antibiotic therapies are sometimes given until microbiological results are available and de-escalation cannot be performed quickly. This review provides an overview of microbial etiology, resistance patterns, epidemiology and microbial diagnosis of pneumonia.

[1]  I. Latorre,et al.  Usefulness of pneumococcal antigen detection in pleural fluid samples by immunochromatographic assay for diagnosis of pneumococcal pneumonia. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  Garrett E. Schramm,et al.  Pseudomonas aeruginosa Nosocomial Pneumonia: Impact of Pneumonia Classification , 2015, Infection Control & Hospital Epidemiology.

[3]  J. M. Porcel,et al.  A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  A. Bilbao,et al.  Etiology of community-acquired pneumonia in a population-based study: Link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes , 2012, BMC Infectious Diseases.

[5]  J. Rello,et al.  Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  E. Walsh,et al.  Respiratory syncytial virus infection in adult populations. , 2012, Infectious disorders drug targets.

[7]  M. de Martino,et al.  Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. , 2009, Clinical therapeutics.

[8]  Peggy Cruse,et al.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Mathias W Pletz,et al.  Detection of Pneumonia Associated Pathogens Using a Prototype Multiplexed Pneumonia Test in Hospitalized Patients with Severe Pneumonia , 2014, PloS one.

[10]  J. Nicolás,et al.  Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. , 1999, American journal of respiratory and critical care medicine.

[11]  J. M. Porcel,et al.  Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. , 2002, Chest.

[12]  A. Torres,et al.  Community-acquired pneumonia in outpatients: aetiology and outcomes , 2012, European Respiratory Journal.

[13]  D. Cook,et al.  Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. , 2000, Chest.

[14]  F. Tubau,et al.  Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. , 2004, Archives of internal medicine.

[15]  Jordi Rello,et al.  Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. , 2002, Chest.

[16]  Ronald N. Jones Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  D. Fleming,et al.  Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study , 2001, The Lancet.

[18]  The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[19]  P. Tulkens,et al.  Multidrug-Resistant Streptococcus pneumoniae Infections , 2012, Drugs.

[20]  G. Barlow,et al.  Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis , 2006, Thorax.

[21]  P. Wyer,et al.  Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia. , 2007, Annals of emergency medicine.

[22]  C. Stuart-harris,et al.  Atypical Pneumonia* , 1950, British medical journal.

[23]  S. Osajima [VIRAL PNEUMONIA]. , 1963, Naika. Internal medicine.

[24]  A. Torres,et al.  Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis , 2011, Critical care.

[25]  D. Chung,et al.  Community-acquired pneumonia requiring hospitalization among U . S . adults , 2016 .

[26]  M. Niederman,et al.  Community-acquired pneumonia related to intracellular pathogens , 2016, Intensive Care Medicine.

[27]  J. Sollet,et al.  [Interest of real-time PCR Xpert MRSA/SA on GeneXpert(®) DX System in the investigation of staphylococcal bacteremia]. , 2011, Pathologie-biologie.

[28]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2005–2013 , 2014, MMWR. Morbidity and mortality weekly report.

[29]  Brian A. King,et al.  Current cigarette smoking among adults - United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.

[30]  M. Postma,et al.  Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis. , 2015, Vaccine.

[31]  R. Dittus,et al.  Influenza– and Respiratory Syncytial Virus–Associated Morbidity and Mortality in the Nursing Home Population , 2003, Journal of the American Geriatrics Society.

[32]  T. Welte,et al.  Clinical and economic burden of community-acquired pneumonia among adults in Europe , 2010, Thorax.

[33]  M. Niederman,et al.  Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa. , 2016, Chest.

[34]  R. Gaynes,et al.  Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.

[35]  F. Blasi,et al.  Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. , 2013, Chest.

[36]  A. Liapikou,et al.  Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome , 2015, Critical Care.

[37]  A. Torres,et al.  Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. , 2015, The Journal of infection.

[38]  A. Puren,et al.  Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[39]  Diego Viasus,et al.  Características clínicas y pronóstico de la neumonía adquirida en la comunidad causada por Staphylococcus aureus resistente a la meticilina , 2014 .

[40]  R. Rodríguez-Roisín,et al.  Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. , 1990, The American review of respiratory disease.

[41]  Jongyoun Yi,et al.  Clinical utility of rapid pathogen identification using matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry in ventilated patients with pneumonia: A pilot study , 2016, Respirology.

[42]  G. Tillotson,et al.  Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004). , 2006, International journal of antimicrobial agents.

[43]  M. Niederman,et al.  Nosocomial pneumonia: lessons learned. , 2013, Critical care clinics.

[44]  S. Zakynthinos,et al.  Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria , 2005, Intensive Care Medicine.

[45]  Mauricio Valencia,et al.  Ventilator-associated pneumonia , 2009, Current opinion in critical care.

[46]  M. Kollef,et al.  Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort , 2012, Infection Control & Hospital Epidemiology.

[47]  J. King,et al.  MATERNAL MORTALITY IN THE UNITED STATES , 1951, American journal of public health.

[48]  J. Ebbert,et al.  Respiratory Syncytial Virus Pneumonitis in Immunocompromised Adults: Clinical Features and Outcome , 2005, Respiration.

[49]  E. Arias,et al.  Mortality in the United States, 2014. , 2015, NCHS data brief.

[50]  A. Bourdin,et al.  Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor , 2004, European Respiratory Journal.

[51]  D. Sinclair,et al.  Nosocomial pneumonia in the intensive care unit. , 1994, British journal of hospital medicine.

[52]  R. Vainionpää,et al.  Diagnostic Value of Bronchoalveolar Lavage in Community-acquired Pneumonia in a Routine Setting: A Study on Patients Treated in a Finnish University Hospital , 2004, Scandinavian journal of infectious diseases.

[53]  F. Baquero,et al.  Factors impacting on length of stay and mortality of community-acquired pneumonia. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[54]  S. Dowell,et al.  Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. , 1996, The Journal of infectious diseases.

[55]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[56]  J. Rello,et al.  Microbiological testing and outcome of patients with severe community-acquired pneumonia. , 2003, Chest.

[57]  J. Dorca,et al.  Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  Jae-Hoon Song,et al.  Respiratory infections due to drug-resistant bacteria. , 2010, Infectious disease clinics of North America.

[59]  F. Blasi,et al.  Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective , 2013, Thorax.

[60]  E. Maltezos,et al.  A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. , 2009, The Journal of infection.

[61]  B. Cao,et al.  Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China , 2013, BMC Infectious Diseases.

[62]  T. Welte,et al.  Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors , 2009, European Respiratory Journal.

[63]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[64]  K. Edwards,et al.  Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. , 2002, Archives of internal medicine.

[65]  R. Wunderink,et al.  The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. , 2001, Respiratory medicine.

[66]  J. Sollet,et al.  Intérêt de la PCR temps réel Cepheid Xpert SAMR/SA sur GeneXpert® DX System dans la prise en charge de la bactériémie à staphylocoque , 2011 .

[67]  M. Fujimura,et al.  Severe community-acquired pneumonia in an intensive care unit: risk factors for mortality. , 2005, Internal medicine.

[68]  M. Niederman,et al.  Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis , 2015, European Respiratory Journal.

[69]  J. Dorca,et al.  Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes , 2009, Thorax.

[70]  J. Dorca,et al.  Declining mortality among hospitalized patients with community-acquired pneumonia. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[71]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[72]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.

[73]  R. Rodríguez-Roisín,et al.  Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.

[74]  Jay Steingrub,et al.  International study of the prevalence and outcomes of infection in intensive care units , 2009 .

[75]  T. Welte,et al.  Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. , 2010, American journal of respiratory and critical care medicine.

[76]  A. Palmu,et al.  Evaluation of the BinaxNOW® Streptococcus pneumoniae antigen test on fresh, frozen and concentrated urine samples in elderly patients with and without community-acquired pneumonia. , 2016, Journal of microbiological methods.

[77]  韩旭东,et al.  Viral pneumonia , 2004 .

[78]  F. Blasi,et al.  Atypical pathogens and respiratory tract infections , 2004, European Respiratory Journal.

[79]  J. Lynch,et al.  Streptococcus pneumoniae: Does Antimicrobial Resistance Matter? , 2009, Seminars in respiratory and critical care medicine.

[80]  N. Wellinghausen,et al.  Rapid detection of Staphylococcus aureus bacteremia and methicillin resistance by real-time PCR in whole blood samples , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[81]  C. Jaca,et al.  Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay , 2010, Infection.

[82]  A. Conway Morris,et al.  Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  J. Rello,et al.  Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet , 2001 .

[84]  G. Sarosi,et al.  The role of atypical pathogens in community-acquired pneumonia. , 2001, The Medical clinics of North America.

[85]  S. Teramoto,et al.  Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. , 2015, Respiratory investigation.

[86]  M. Kollef,et al.  A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. , 2000, Chest.

[87]  M. Wolff,et al.  Incidence and outcome of polymicrobial ventilator-associated pneumonia. , 2002, Chest.

[88]  J. Carlet,et al.  Ventilator-associated pneumonia. European Task Force on ventilator-associated pneumonia. , 2001, The European respiratory journal.

[89]  C. Esquinas,et al.  Microbial aetiology of community-acquired pneumonia and its relation to severity , 2011, Thorax.

[90]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[91]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[92]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  M. Cetron,et al.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.

[94]  R. Albert,et al.  The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia. , 2015, American journal of respiratory and critical care medicine.

[95]  A. Anzueto,et al.  Economic Burden of Ventilator-Associated Pneumonia Based on Total Resource Utilization , 2008, Infection Control & Hospital Epidemiology.